MitraClip device for patients at moderate risk for surgery

Trial ID:
IRB-20-7647
Matthew J Price, M.D.
The purpose of this research is to extend the current approved indication of the MitraClip device to include patients who are considered moderate-risk candidates for traditional mitral valve repair surgery.

Inclusion Criteria

Patients must:

  • Must be 18 years old or older
    Must be at moderate surgical risk for mitral valve repair
    Must have severe mitral regurgitation
    Be willing to participate in the trial for 10 years

Exclusion Criteria

Patients must not:

  • Be currently participating in another clinical trial
    Have secondary mitral regurgitation
    Have severe tricuspid regurgitation or severe valve disease
    Have had a heart attack in the last year

Additional Info

The MitraClip device is currently approved by the FDA for patients who are at high-risk for traditional surgery, but is not approved for patients considered moderate to low surgical risk.

All treatments and physician visits during this study will take place at Anderson Medical Pavilion, Scripps La Jolla. Study participation will last up to 10 years

Contact Info:

  • Clinical Research Services
  • gil-flamer.john@scrippshealth.org